controlledSubstanceSchedule
225
triples
GPTKB property
Alternative names (5)
controlledSubstance • controlledSubstanceIn • is a controlled substance in • isControlledSubstance • isControlledSubstanceInRandom triples
| Subject | Object |
|---|---|
| gptkb:thebaine | gptkb:Australia |
| gptkb:Targiniq_ER | gptkb:Schedule_II_(US) |
| gptkb:diphenoxylate | Schedule II (US, when alone) |
| gptkb:anabolic_steroids | gptkb:Canada |
| gptkb:Dolophine | gptkb:Schedule_II_(US) |
| gptkb:Xywav | gptkb:Schedule_III_(US) |
| gptkb:ProCentra | gptkb:Schedule_II |
| gptkb:Thebaine | gptkb:United_States |
| gptkb:Eszopiclone | Schedule IV (US) |
| gptkb:Ketalar | gptkb:Schedule_III_(US) |
| gptkb:thebaine | gptkb:Canada |
| gptkb:Suboxone | gptkb:Schedule_III_(US) |
| gptkb:ephedrine | gptkb:Canada |
| gptkb:Equipoise | gptkb:United_States |
| gptkb:diphenoxylate | Schedule V (US, when combined with atropine) |
| gptkb:methylphenidate | gptkb:Schedule_II_(US) |
| gptkb:methylphenidate | gptkb:Schedule_III_(Canada) |
| gptkb:Daytrana | gptkb:Schedule_II |
| gptkb:codeine_phosphate | Schedule III (US, in combination) |
| gptkb:hydromorphone | gptkb:Schedule_II_(US) |